For the Inventor, By the Inventor

Enter assignee name

Chappaqua, NY, United States of America

Biotheryx, Inc.

USPTO Granted Patents = 39

EPO Patents = 3

Trademarks = 2

Forward Citations = 75

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Frank Mercurio (34 out of 49 patents)

Kyle W H Chan (33 out of 47 patents)

Leah M Fung (29 out of 37 patents)

4. Robert W Sullivan (28 out of 58 patents)

5. Paul E Erdman (25 out of 39 patents)

6. Eduardo Torres (14 out of 96 patents)

7. Aparajita Hoskote Chourasia (10 out of 10 patents)

8. Imelda Lam (5 out of 5 patents)

9. David Aaron Hecht (4 out of 4 patents)

10. Armen Manoukian (4 out of 6 patents)

11. Sam Scanga (4 out of 6 patents)

12. Fabrizio Mastronardi (4 out of 7 patents)

13. David I Stirling (3 out of 43 patents)

14. Joseph P Vacca (3 out of 110 patents)

15. Patrick Papa (2 out of 28 patents)

39 patents: Sort by Forward Citations

1. 12662467 - Isoindolinones, pharmaceutical compositions, and therapeutic applications (2026-06-23),

2. 12630547 - RAS protein degraders, pharmaceutical compositions thereof, and their therapeutic applications (2026-05-19),

3. 12522612 - PDE4 inhibitors, pharmaceutical compositions, and therapeutic applications (2026-01-13),

4. 12419962 - Quinazolines, pharmaceutical compositions, and therapeutic applications (2025-09-23),

5. 11400084 - Aminoamide compounds (2022-08-02),

6. 11352338 - Substituted isoindolinones (2022-06-07),

7. 11345714 - Compounds targeting proteins, compositions, methods, and uses thereof (2022-05-31),

8. 11345712 - Protein-targeting compounds and pharmaceutical compositions thereof, and their therapeutic applications (2022-05-31),

9. 11236105 - Bicyclic compounds and methods of use (2022-02-01),

10. 11236103 - Bifunctional compounds (2022-02-01),

11. 11191769 - Fused thiophene compounds (2021-12-07),

12. 11072599 - Pyrazole compounds and uses thereof (2021-07-27),

13. 10960003 - Pyrazole pyrimidine derivative and uses thereof (2021-03-30),

14. 10927104 - Ether compounds and uses thereof (2021-02-23),

15. 10905684 - Aminoamide compounds (2021-02-02),

BioTheryX is a biopharmaceutical company focused on the development and commercialization of innovative targeted therapies for cancer treatment. With a strong emphasis on precision medicine, their mission is to improve patient outcomes by delivering highly effective and safe therapies that specifically target the underlying mechanisms of cancer progression. BioTheryX has a diverse portfolio of novel drug candidates that are designed to address unmet medical needs and offer new treatment options for patients. Through rigorous research and strategic collaborations, they strive to advance the field of oncology and provide hope to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

39 Patents

#1 in Chappaqua, NY

#541 in New York

#8,810 in US

#17,413 in the World

Chappaqua, NY, United States of America

Biotheryx, Inc.

Forward Citations = 75

26 inventors:

Frank Mercurio (34 out of 49 patents)

Kyle W H Chan (33 out of 47 patents)

Leah M Fung (29 out of 37 patents)

4. Robert W Sullivan (28 out of 58 patents)

5. Paul E Erdman (25 out of 39 patents)

Please report any incorrect information to [email protected]

Loading…